Company Filing History:
1 out of 20 
1 out of 832,966 Years Active: 1999-2004
Title: Hannu Sariola: Innovator in Neurotrophic Factor Research
Introduction
Hannu Sariola is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of neurotrophic factors, particularly through his innovative patents. With a total of 2 patents, Sariola's work has advanced our understanding of glial cell line-derived neurotrophic factors and their applications.
Latest Patents
Sariola's latest patents include groundbreaking research on assays using glial cell line-derived neurotrophic factor receptors. These patents disclose the cellular expression, isolation, biochemical characterization, and sequences of receptors for glial cell line-derived neurotrophic factor (GDNF). Notably, c-RET is identified as one receptor for GDNF, along with additional novel receptors. Furthermore, his patents detail the preparation of monoclonal antibodies directed against GDNF. Another significant patent addresses the regulation of ureteric morphogenesis by GDNF, outlining methods for stimulating budding and branching of the ureteric epithelium, promoting axonal outgrowth, maintaining ureteric epithelial cells in culture, preventing apoptosis of these cells, and treating diseases using GDNF.
Career Highlights
Throughout his career, Sariola has worked with various organizations, including Licentia, Ltd. His research has been pivotal in the field of neurobiology, particularly in understanding the role of neurotrophic factors in kidney development and neuronal health.
Collaborations
Sariola has collaborated with notable colleagues such as Mart Saarma and Petro Suvanto. These partnerships have further enriched his research and contributed to the advancement of knowledge in neurotrophic factors.
Conclusion
Hannu Sariola's contributions to the field of neurotrophic factors through his patents and collaborations highlight his role as an innovator in biomedical research. His work continues to influence the understanding and treatment of various diseases related to neurotrophic factors.